GSEA and co-expression analysis revealed that tumor tissues with high CXCR2P1 expression exhibited significant activation of the PD-1 signaling pathway, IFN signaling pathway, Toll-like receptor signaling pathway, and JAK-STAT signaling pathway. The gene discussed is CXCR2P1; the disease is neoplasm.